What does it take for a second medical use to be sufficiently disclosed? A list of indications in the application? Clinical data? Or something in-between?
How do Courts address inventiveness of a second medical use patent in light of the first medical use? Also, what issues arise with disclosure of clinical trial protocols?
Join members of Gowling WLG's global intellectual property team for a webinar to get answers to these questions and more. We will look at the validity of second medical use patents across the UK, Canada, Russia and China, and help you understand what to expect when the validity of a second medical use patent is called into question.